Axsome Therapeutics, Inc. (AXSM) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$34,394
Total Return
243.94%
CAGR
28.03%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +4.01% |
| Median | +2.00% |
| Best | +102.25% |
| Worst | -65.14% |
| % of Windows Positive | 55.7% |
1-Year (252 Trading Days)
| Average | +45.34% |
| Median | +36.70% |
| Best | +296.04% |
| Worst | -67.66% |
| % of Windows Positive | 86.6% |
3-Year (756 Trading Days)
| Average | +166.16% |
| Median | +161.87% |
| Best | +379.58% |
| Worst | +5.89% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -72.91% |
| Average Drawdown | -22.69% |
| Drawdown Duration | 359 Trading Days |
| Sortino Ratio | 1.13 |
| Calmar Ratio | 0.38 |
| CVaR (5%) | -8.42% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +0.84% (+2.99% ann.) | +$84.32 | $0.00 | $0.00 | $0.00 |
| 2025 | +115.86% | +$11586.10 | $0.00 | $0.00 | $0.00 |
| 2024 | +6.31% | +$630.73 | $0.00 | $0.00 | $0.00 |
| 2023 | +3.19% | +$318.94 | $0.00 | $0.00 | $0.00 |
| 2022 | +104.16% | +$10415.57 | $0.00 | $0.00 | $0.00 |
| 2021 | -53.63% | $5362.71 | $0.00 | $0.00 | $0.00 |
| 2020 | -21.18% | $2117.84 | $0.00 | $0.00 | $0.00 |
| 2019 | +3565.25% | +$356525.35 | $0.00 | $0.00 | $0.00 |
| 2018 | -49.64% | $4964.29 | $0.00 | $0.00 | $0.00 |
| 2017 | -17.04% | $1703.70 | $0.00 | $0.00 | $0.00 |
| 2016 | -27.18% | $2718.45 | $0.00 | $0.00 | $0.00 |
| 2015 partial | +6.06% (+66.86% ann.) | +$606.41 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 19, 2015 – February 19, 2020 | +954.35% | +74.02% | +$95434.79 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -30.98% | -98.55% | $3097.53 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +1.08% | +1.74% | +$107.88 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -50.10% | -48.29% | $5010.17 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +70.87% | +76.62% | +$7087.44 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +56.01% | +27.12% | +$5601.30 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +101.20% | +56.15% | +$10120.16 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.